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with embryonic 4 globin in screening for ct
thalassaemia
L C Chan, J C C So, D H K Chui
Abstract
Aims-To compare the haemoglobin (Hb)
H inclusion test with immunocytochem-
ical detection of embryonic 4 chains in
screening for a thalassaemia.
Methods-Blood samples from 115 patients
with relevant clinical history and hypo-
chromic microcytic indexes were screened
using the HbH inclusion test and the Vari-
ant Hemoglobin Testing System (BioRad,
Hercules, CA, USA).
Results-The HbH inclusion test was
positive in 61 of 115 cases, three of whom
had HbH disease confirmed by electro-
phoresis. The remaining 58 had a thal-
assaemia 1. All three HbH cases and 56
of 58 cases of a thalassaemia 1 expressed
embryonic 4 chains, giving a specificity of
96-7%. Fifty four of115 cases had a negative
HbH inclusion test, of whom 50 had P
thalassaemia trait and three had iron de-
ficiency. No diagnosis was reached for the
remaining patient.
Conclusion-The immunocytochemical
test is as sensitive as the HbH inclusion
test in screening for a thalassaemia. The
presence of 4 chains is highly specific for a
thalassaemia 1 incorporating the (--/SEA)
deletion. The specificity and simplicity of
the immunocytochemical test make it the
test of choice in screening for a thal-
assaemia.
(JT Clin Pathol 1995;48:861-864)
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In South East Asia, where a and thalassaemia
are prevalent, the haemoglobin (Hb) H in-
clusion test, based on incubation of eryth-
rocytes in brilliant cresyl blue, is used
extensively in many laboratories as a screening
test for subjects with a thalassaemia. The pres-
ence of HbH inclusions is correlated with the
aocl-- genotype (including those with deletions
involving the complete 4-a gene cluster) as
present in oa thalassaemia 1 carriers and the
a-/-- genotype associated with HbH disease.'
Based on positive findings, couples at risk of
producing fetuses with hydrops fetalis due to
Hb Barts are identified for genetic counselling
and prenatal diagnosis. Recently, an im-
munocytochemical test which detects em-
bryonic 4 chain in erythrocytes was shown to be
highly specific and sensitive for a thalassaemia 1
carriers of the (--SEA/) deletion'-that is, the
oca/-- genotype in which the 4 globin gene
cluster is intact. We have compared the HbH
inclusion test with immunocytochemical
detection of 4 globin chains in screening for a
thalassaemia.
Methods
Blood samples from 115 patients with relevant
clinical history and microcytic (mean cor-
puscular volume (MCV) < 80 fl) and hypo-
chromic indexes were subjected to the following
studies: (1) HbH inclusion test; (2) estimation
of HbA2 and HbF by the Variant Hemoglobin
Testing System3 (BioRad, Hercules, California,
USA); and (3) electrophoresis of the haem-
olysate in cellulose acetate at pH 8-55 using
the Super Z kit Hb system as appropriate.
Using the Variant Hemoglobin Testing System,
the normal adult reference ranges for HbA2
and HbF in our laboratory are, respectively,
2 3-3O0% and 0-0 9% (unpublished data). The
normal adult reference range for MCV in our
local population, based on determination of
erythrocyte indexes using the Technicon H*1
blood analyzer, is 83-96 fl.4 Serum iron and
serum ferritin concentrations were determined
in 40 cases.
HBH INCLUSION TEST
Air dried peripheral blood smears were made
from a mixture of two parts 1% brilliant cresyl
blue to one part blood following incubation at
37°C for exactly 30 minutes. For detection of
inclusions, 1000 to 5000 red blood cells were
examined under an oil immersion lens which
requires up to 15 minutes per case.
DETECTION OF EMBRYONIC 4 CHAINS
Air dried peripheral blood smears were fixed
in a solution containing 90% absolute acetone
and 10% absolute methanol at room tem-
perature for five to 10 minutes. They were then
washed in phosphate buffered saline (PBS)
containing 3% bovine serum albumin (BSA);
10 ml of a 1 in 20 dilution of murine mono-
clonal antihuman 4 globin chain conjugated
with fluorescein isothiocyanate was then added.
The slides were incubated in a humidified
chamber at room temperature for 30 minutes
and were then washed in BSA free PBS, covered
with glycerol and examined under a fluor-
escence microscope (Zeiss). Cord blood and
blood from an individual with a normal full
blood count were used as positive and negative
controls, respectively, for 4 globin expression.
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1=5'-GCGATCTGGGCTCTGTGTTCT-3'
2=5'-GTTCCCTGAGCCCCGACACG -3'
3=5'-ACTGCAGCCTTGAACTCCTG -3'
Figure 1 Alpha globin gene loci and primers for PCR analysis.
DNA EXTRACTION AND POLYMERASE CHAIN
REACTION
DNA was extracted from peripheral blood
using a commercial kit (Intragene Purification
Matrix; BioRad). To detect the (--/SEA) de-
letion, three primers were synthesised using
details of the sequences provided by Chang et
al5 (fig 1). Primers 1 and 2 amplify a 314
nucleotide band if normal or if a thalassaemia
2 is present, whereas a thalassaemia 1 with the
(--/SEA) genotype will yield a 195 nucleotide
band on amplification with primers 1 and 3.
DNA (250 ng) was amplified using the poly-
merase chain reaction (PCR) with primers at
a final concentration of 2 mtM for 35 cycles on
Figure 2 Immunofluorescent erythrocytes stained with anti-C chain antibody in a case of
ax thalassaemia 1. (Magnification x 2000.)
an automated themocycler under the following
conditions: denaturation at 94°C for 30 sec-
onds, annealing at 58°C for 45 seconds and
extension at 72°C for one minute, except for
the first cycle when denaturation took place at
95°C for 90 seconds and at 94°C for 30 sec-
onds. After amplification, DNA was elec-
trophoresed on a 2% agarose gel at 100 V
for one hour and visualised using ethidium
bromide.
STATISTICAL ANALYSIS
The sensitivity and specificity of the im-
munocytochemical test for the diagnosis of ax
thalassaemia were calculated as described by
Simel.6
Results
The HbH inclusion test was positive in 61 of
the 115 cases studied. Three of these 61
patients had HbH disease based on the pres-
ence of multiple inclusions and a HbH band
on electrophoresis. In the remaining 58 the
pattern ofHbH inclusions was compatible with
a diagnosis of a thalassaemia 1. All three cases
of HbH disease expressed embryonic 4 chains
as did 56 of the 58 cases of a thalassaemia 1.
Therefore, the sensitivity of the immuno-
cytochemical test compared with conventional
methods for the diagnosis of a thalassaemia
was 96-7% (59/59+2). Figure 2 shows the
fluorescence pattern of erythrocytes, revealing
varying staining intensities in a patient with1a
thalassaemia 1.
Of the two patients (cases 47 and 71) with
HbH inclusions, but without embryonic 4
chains, one had iron deficiency anaemia whilst
the other had an unexplained hypochromic
microcytic anaemia with no family history of
thalassaemia. As expected, the (-/SEA) de-
letion was not detected on DNA analysis of
the a globin locus by PCR in both of these
cases. By contrast, an amplified band of 195
base pairs, confirming the presence of the (--/
SEA) deletion, was present in all seven cases
of a thalassaemia 1-that is, both HbH and 4
chain positive. The results of the DNA analysis
are presented in fig 3.
Fifty four cases had a negative HbH inclusion
test. Fifty had thalassaemia trait based on
raised A2 and F concentrations and three were
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Figure 3 An ethidium bromide stained agarose gel ofDNA amplified from cases 1 (HbH positive, 4 chain positive),
47 and 71. Lane A, primers 1 and 2; lane B, primers 1 and 3; M, DNA markers.
1 15 cases (MCV < 80 fl)
HbH positive
(n = 61)
HbH disease a Thalassaemia
pattern (n = 3) (n = 58)
(confirmed by
electrophoresis)
-all 4 chain positive
4 positive
(n = 56)d
HbH negative
(n = 54)
P Thalassaemia Iron deficiency (n = 3)b
(n = 50)a Unknown (case 74)c
4 negative
(n = 2)e
-iron deficiency (case 71)
-unexplained (case 47)
Figure 4 Flow chart of results of the HbH inclusion test and C globin chain expression. aFive offive cases 4 chain
negative; btwo of two cases C chain negative; 'C chain positive; seven of seven cases (CISEA) positive; '(-ISEA)
negative.
iron deficient. The 4 chain was expressed in
the patient (case 74) whose iron status was
unknown and whose HbH inclusion test was
negative, but not in the five cases of ,B thal-
assaemia and two cases of iron deficiency ex-
amined. As no DNA was available to resolve
the oa globin status of case 74, the specificity
ofthe immunocytochemical test compared with
conventional methods (after excluding case 74)
for the diagnosis of oa thalassaemia was 100%
(7/0 + 7). A summary of the data is shown in
fig 4.
Discussion
The immunocytochemical detection of em-
bryonic 4 chains is as sensitive as the HbH
inclusion test in screening for a thalassaemia.
Embryonic 4 chains were present in 56 (96 5%)
of 58 cases of oa thalassaemia 1 based on a
positive HbH inclusion test. Of the two cases
(47 and 74) which did not express the 4 chain,
DNA analysis confirmed that the (--/SEA) de-
letion was absent as expected. It is possible
that, in these two cases, the 4 genes were deleted
together with the oa gene loci, as is the case in
adult carriers of deletions such as (--Fill),
(-- Thai/), and (--HW/) in South East Asia.78
Case 47 had a negative discriminant func-
tion as calculated using red blood cell indexes9
which is in keeping with the diagnosis of a thal-
assaemia. Other possibilities which may
account for negative 4 chain expression
include the -al- oa, -a/aCsot and ----/C4aax'
genotypes, or a "false positive" HbH inclusion
test.
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We have also shown that the immuno-
cytochemical test is highly specific for the diag-
nosis ofa thalassaemia 1. However, the 4 globin
chain was also detected in a single case (case
74) for whom the HbH inclusion test was
negative. As the HbF and A2 concentrations
were normal and no variant haemoglobins were
detected, the absence ofHbH inclusions cannot
be because of the presence of f thalassaemia
trait or HbE, both of which are known to
decrease significantly the number of HbH in-
clusions.' As no cells were stored for DNA
analysis, we cannot confirm whether the (-
SEA/) deletion was present using PCR.
We have shown that the immunocyto-
chemical detection of embryonic 4 chains is a
practical alternative to the HbH inclusion test
in the diagnosis of oc thalassaemia. As staining
is positive in almost all erythrocytes, only small
numbers of red cells need to be evaluated
compared with the laborious screening of sev-
eral fields for the detection ofHbH inclusions.
Detection of 4 chains using immunofluor-
escence can be carried out in batches and the
results can be rapidly scored and assigned as
definitively positive or definitively negative.
It must be emphasised that screening for
embryonic 4 chains, like all laboratory tests,
will need to be interpreted together with other
relevant clinical and laboratory data. In a few
patients with 4-oc thalassaemia the immuno-
cytochemical test will be negative but the HbH
inclusion test will be positive. Therefore, we
recommend that screening for oc thalassaemia
be undertaken using 4 chain detection; negative
cases must be confirmed using appropriate mo-
lecular analysis.
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